HungaroTrial is featured in a recent article in the leading news media in South Korea.
HungaroTrial CRO is pleased to announce the publishing of a recent article where our company was featured in Biospectator, the leading news media in South Korea focused on the biotechnology industry.
The article presents the benefits of a collaboration between Korea and Eastern Europe in clinical research. Our CEO, Lajos Sarosi, MD describes the recent collaboration between HungaroTrial and Korean Biotech and Pharma companies, featuring highlights of lessons learned.
To read the article in full, visit:
http://www.biospectator.com/view/news_view.php?varAtcId=12998
HungaroTrial is committed to further developing parntnerships with Korean pharmaceutical and biotech companies in their development programs by accelerating their enrolment process through fast start-up and implementation of clinical trials in Eastern Europe.
